omega-n-methylarginine has been researched along with perindopril in 1 studies
Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (perindopril) | Trials (perindopril) | Recent Studies (post-2010) (perindopril) |
---|---|---|---|---|---|
4,411 | 344 | 336 | 1,829 | 556 | 497 |
Protein | Taxonomy | omega-n-methylarginine (IC50) | perindopril (IC50) |
---|---|---|---|
Angiotensin-converting enzyme | Homo sapiens (human) | 0.0015 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Shimabukuro, M; Tagawa, T; Ueda, S; Watanabe, S; Yamakawa, K | 1 |
1 trial(s) available for omega-n-methylarginine and perindopril
Article | Year |
---|---|
Inhibition of the renin-angiotensin system prevents free fatty acid-induced acute endothelial dysfunction in humans.
Topics: Acetylcholine; Adult; Anticoagulants; Antihypertensive Agents; Endothelium, Vascular; Enzyme Inhibitors; Fatty Acids, Nonesterified; Heparin; Humans; Lipids; Losartan; Male; omega-N-Methylarginine; Perindopril; Plethysmography; Regional Blood Flow; Renin-Angiotensin System; Vasodilation; Vasodilator Agents | 2005 |